Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

Why Investors Should Bet on Canopy Growth Now as it Readies for Later

By Chris Lau, InvestorPlace Contributor

CGC stock got a lift from production closures worldwide, so as its cost basis shrinks, Canopy Growth will eventually earn profits.

With Limited Downside Ahead, ConocoPhillips Stock Is a Buy

By Chris Lau, InvestorPlace Contributor

ConocoPhillips stock will resist further big drops despite management forecasting higher prices, mostly because of its strong balance sheet.

Delta Stock Will Survive the Rough Storms Ahead

By Chris Lau, InvestorPlace Contributor

Delta has the advantage of avoiding the Boeing MAX 737 mess, but there's more to like in DAL stock.

7 Cash-Rich Oil Stocks That Will Survive This Crisis

By Chris Lau, InvestorPlace Contributor

Covid-19 is an opportunity for investors to buy strong oil companies on the sector dip. Weaker energy demand means cash on hand is a must.

Advanced Micro Devices Stock Set to Climb as Chips Make Tech Inroads

By Chris Lau, InvestorPlace Contributor

AMD stock will get a lift from a solid product road map ahead in gaming laptops, EPYC and desktop chips in 2020.

Load More